| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | -0.18 | 2e-06 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.2 | 3e-05 |
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | -0.16 | 3e-05 |
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | -0.16 | 9e-05 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.22 | 0.0001 |
| mRNA | IPA-3 | GDSC1000 | pan-cancer | AAC | -0.14 | 0.0002 |
| mRNA | HG-5-113-01 | GDSC1000 | pan-cancer | AAC | -0.2 | 0.0002 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.22 | 0.0002 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0003 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0003 |